Navigating evidence-based care with limited resources in Africa

Dr Verna Vanderpuye - National center for Radiotherapy and Nuclear Medicine, Accra, Ghana
Navigating evidence-based care with limited resources in Africa ( Dr Verna Vanderpuye - National center for Radiotherapy and Nuclear Medicine, Accra, Ghana )
9 Mar 2023

Choosing Wisely in Tanzania

Dr Jerry Ndumbalo - Ocean Road Cancer Institute, Dar es Salaam, Tanzania
Choosing Wisely in Tanzania ( Dr Jerry Ndumbalo - Ocean Road Cancer Institute, Dar es Salaam, Tanzania )
8 Mar 2023

Choosing Wisely in multiple myeloma

Dr Hamisa Iddy - Ocean Road Cancer Institute, Dar es Salaam, Tanzania
Choosing Wisely in multiple myeloma ( Dr Hamisa Iddy - Ocean Road Cancer Institute, Dar es Salaam, Tanzania )
8 Mar 2023

Choosing Wisely in surgical oncology

Prof Larry Akoko - Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania
Choosing Wisely in surgical oncology ( Prof Larry Akoko - Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania )
8 Mar 2023

Advocacy that impacts patient outcomes in Africa

Mr Franklin Mtei - Inspire2Live, Dar es Salaam, Tanzania
Advocacy that impacts patient outcomes in Africa ( Mr Franklin Mtei - Inspire2Live, Dar es Salaam, Tanzania )
8 Mar 2023

Choosing Wisely in pathology

Dr Angela Mlole - Ocean Road Cancer Institute, Dar es Salaam, Tanzania
Choosing Wisely in pathology ( Dr Angela Mlole - Ocean Road Cancer Institute, Dar es Salaam, Tanzania )
8 Mar 2023

Choosing Wisely campaigns in Africa

Dr Fidel Rubagumya - Rwanda Military Hospital, Kigali, Rwanda
Choosing Wisely campaigns in Africa ( Dr Fidel Rubagumya - Rwanda Military Hospital, Kigali, Rwanda )
8 Mar 2023

Childhood cancer: the surprising scientific facts

Dr Mlis Ratha - Calmette Hospital, Phnom Penh, Cambodia
Childhood cancer: the surprising scientific facts ( Dr Mlis Ratha - Calmette Hospital, Phnom Penh, Cambodia )
7 Mar 2023

IORT at Institute Paoli-Calmettes in France

Dr Agnes Tallet - Institute Paoli-Calmettes, Marseille, France
IORT at Institute Paoli-Calmettes in France ( Dr Agnes Tallet - Institute Paoli-Calmettes, Marseille, France )
6 Mar 2023

Pembrolizumab plus docetaxel used to treat patients with metastatic castration-resistant prostate cancer

Prof Daniel Petrylak - Yale University Cancer Center, New Haven, USA
Pembrolizumab plus docetaxel used to treat patients with metastatic castration-resistant prostate cancer ( Prof Daniel Petrylak - Yale University Cancer Center, New Haven, USA )
6 Mar 2023

SG monotherapy demonstrates a high response rate in PT-ineligible patients with mUC who progressed after CPI therapy

Prof Daniel Petrylak - Yale University Cancer Center, New Haven, USA
SG monotherapy demonstrates a high response rate in PT-ineligible patients with mUC who progressed after CPI therapy ( Prof Daniel Petrylak - Yale University Cancer Center, New Haven, USA )
6 Mar 2023

IORT at the WITS University in South Africa

Prof Carol Benn - WITS University, Johannesburg, South Africa
IORT at the WITS University in South Africa ( Prof  Carol Benn - WITS University, Johannesburg, South Africa )
6 Mar 2023